Money Talks News on MSN
CRISPR cures cholesterol, FDA demands testing
Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...
A new skin-applied gene therapy uses lipid nanoparticles to deliver gene editing into skin stem cells, correcting ...
Gene therapy is a medical treatment that works by changing or fixing a person's genes to treat or prevent disease ...
Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy - Methods & Clinical Development, describing the application of optical genome mapping (OGM) to ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) expected to beat earnings estimates: Should you buy?
CRISPR Therapeutics AG (CRSP) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports ...
Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.
The United Arab Emirates and Colossal Biosciences have announced the creation of the first Colossal BioVault and World ...
Key takeawaysTau is the most common protein that aggregates in neurodegeneration diseases. However, researchers had not ...
Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programsVispa-cel (CB-010) ANTLER phase 1 translational and clinical data ...
Artificial intelligence (AI) isn't the only industry with explosive growth potential.
Civitai—an online marketplace for buying and selling AI-generated content, backed by the venture capital firm Andreessen Horowitz—is letting users buy custom instruction files for generating celebrity ...
At the weekend in Kampala, a piece of news landed that could reshape the future of one of the world’s most neglected diseases. The United States Patent and Trademark Office (USPTO) had accepted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results